A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [31] Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer:: final results of a multicenter phase II study
    Monnet, I
    de Cremoux, H
    Soulié, P
    Saltiel-Voisin, S
    Bekradda, M
    Saltiel, JC
    Brain, E
    Rixe, O
    Yataghene, Y
    Misset, JL
    Cvitkovic, E
    ANNALS OF ONCOLOGY, 2002, 13 (01) : 103 - 107
  • [32] Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer
    Xu, Z.
    Xu, C.
    Wang, W.
    Xu, Q.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Shi, M.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2074 - S2074
  • [33] A Phase II Single-Arm Trial of Apatinib as Maintenance Treatment Following First-Line Chemotherapy in Extensive Stage Small Cell Lung Cancer
    Teng, F.
    Xing, P.
    Wang, Y.
    Hu, X.
    Lin, L.
    Li, J.
    Hao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1190 - S1190
  • [34] A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer
    Hobdy, EM
    Kraut, E
    Masters, G
    Blum, K
    McKeon, A
    Byrd, B
    Davies, M
    Beaulieu, N
    Murren, JR
    CANCER BIOLOGY & THERAPY, 2004, 3 (01) : 89 - 93
  • [35] A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
    Yang, Mi
    Liu, Xiufeng
    Zhang, Cheng
    Liao, Feng
    Li, Zixiong
    Luo, Xianwen
    Sun, Yiran
    Chen, Chao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8869 - 8876
  • [36] A PHASE I STUDY OF EVEROLIMUS PLUS PACLITAXEL IN PATIENTS WITH SMALL CELL LUNG CANCER
    Sun, Jong-Mu
    Lee, Jeeyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1345 - S1346
  • [37] Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
    Nogami, Naoyuki
    Tokito, Takaaki
    Zenke, Yoshitaka
    Satouchi, Miyako
    Seto, Takashi
    Saka, Hideo
    Ohtani, Junko
    Han, Shirong
    Noguchi, Kazuo
    Nishio, Makoto
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 136 - 144
  • [38] Salvage treatment with apatinib for advanced non-small-cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Lou, Guangyuan
    Shi, Xun
    Zhang, Yiping
    ONCOTARGETS AND THERAPY, 2017, 10 : 1821 - 1825
  • [39] Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
    Naoyuki Nogami
    Takaaki Tokito
    Yoshitaka Zenke
    Miyako Satouchi
    Takashi Seto
    Hideo Saka
    Junko Ohtani
    Shirong Han
    Kazuo Noguchi
    Makoto Nishio
    Investigational New Drugs, 2024, 42 : 136 - 144
  • [40] Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: A multicentre phase II study
    Rapti, A
    Agelidou, A
    Stergiou, I
    Agelidou, M
    Nikolakopoulos, L
    Varthalitis, J
    Kalykaki, A
    Chainis, K
    Tzanakis, N
    Georgoulias, V
    LUNG CANCER, 2005, 49 (02) : 241 - 244
12345